Judge Reduces $100 Million Propulsid Verdict
March 6, 2002
A Mississippi Circuit Court judge has reduced a $100 million verdict in a case involving Johnson & Johnson's heartburn drug Propulsid. The former Propulsid users filed suit against the manufacturer of the drug, Janssen Pharmaceutica, a subsidiary of Johnson & Johnson, alleging that Propulsid caused their serious heart rhythm disturbances. The jury found in their favor last September. Judge Lamar Pickard decreased the award to $48 million on appeal.
In 1993 the Food and Drug Administration (FDA) approved Propulsid, also known as cisapride, for the treatment of heartburn. Janssen removed the drug from the market in the summer of 2000 after dozens became seriously ill and several died from heart arrhythmias caused by Propulsid.
A spokesperson for Janssen, calling the reduction unacceptable, said the company was pursuing an appeal with the Mississippi State Supreme Court to throw out the judgment.
-- Article Courtesy of InjuryBoard.com
More ...
- Propulsid Lawsuits May Increase
- Parents Sue Doctor Who Gave Child Propulsid
- Propulsid's Warning Label Ignored
.